Notify me when TANG CAPITAL PARTNERS LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | Common Stock, par value $0.01 per share | 6.4% | $2,321,853 | 1,682,502 | TANG CAPITAL MANAGEMENT, LLC | 31 Dec 2024 | ||
| ALXO | ALX Oncology Holdings, Inc. | Common Stock, par value $0.001 per share | 6.3% | $1,615,473 | 3,296,883 | TANG CAPITAL MANAGEMENT, LLC | 31 Dec 2024 | ||
| MRNS | Marinus Pharmaceuticals, Inc. | Common Stock, par value $0.001 per share | 3% | $903,070 | 1,641,945 | TANG CAPITAL MANAGEMENT, LLC | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|